PULSION Medical Systems SE engages in the development, production, and distribution of monitoring, diagnostic, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include the PiCCO2 platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex, which offers technology in the field of perioperative medicine; PiCCO catheter used to monitor the cardiovascular system; and ProAQT, a sensor used in medicine for high-risk patients and high-risk interventions. The company was founded in 1990 and is headquartered in Feldkirchen, Germany.
Frequently asked questions
What sector does PULSION Medical Systems SE (PUS) operate in?
PULSION Medical Systems SE belongs to the Healthcare sector and operates in the Medical Devices industry.
What is PULSION Medical Systems SE (PUS) current stock price?
As of the latest data, PULSION Medical Systems SE stock price is €21.60, with a previous close of €21.60.
What is PULSION Medical Systems SE (PUS) current market capitalization?
PULSION Medical Systems SE market cap is approximately 178.09 million.
What is PULSION Medical Systems SE (PUS) Earnings Per Share (EPS)?
The trailing EPS is €1.88.
What is PULSION Medical Systems SE (PUS) Price-to-Earnings (P/E) ratio?
PULSION Medical Systems SE current P/E ratio is 11.49.
Does PULSION Medical Systems SE (PUS) pay dividends?
No. PULSION Medical Systems SE does not pay a dividend.
What is PULSION Medical Systems SE (PUS) beta (volatility) score?
PULSION Medical Systems SE has a beta of 0.152, indicating lower volatility than the overall market.
